Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study / Galimberti, Sara; Ciabatti, Elena; Ercolano, Giacomo; Grassi, Susanna; Guerrini, Francesca; Cecconi, Nadia; Rousseau, Martina; Cervetti, Giulia; Mazziotta, Francesco; Iovino, Lorenzo; Falzetti, Franca; Falcinelli, Flavio; Bosi, Alberto; Rigacci, Luigi; Kovalchuk, Sofia; Vallisa, Daniele; Macchia, Lucia; Ciancia, Eugenio; Petrini, Mario. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - ELETTRONICO. - 8:(2017), pp. 25-30. [10.3389/fphar.2017.00413]
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study
BOSI, ALBERTO;Kovalchuk, Sofia;
2017
Abstract
Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma
| File | Dimensione | Formato | |
|---|---|---|---|
|
fphar-08-00413.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
452.17 kB
Formato
Adobe PDF
|
452.17 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
